NIFTY 50▼23,995.35
-309.00 (-1.27%)
SENSEX▼78,782.24
-941.88 (-1.18%)
NIFTY BANK▼51,215.25
-458.65 (-0.89%)
TATA MOTORS▼824.10
-19.35 (-2.29%)
SUZLON ENERGY▼66.32
-1.82 (-2.67%)
TATA STEEL▼146.95
-2.80 (-1.87%)
INDIAN RAILWAY FINANCE CORP▼153.24
-4.87 (-3.08%)
TATA POWER▼429.05
-16.40 (-3.68%)
RAIL VIKAS NIGAM▼446.20
-24.75 (-5.26%)
RELIANCE INDUSTRIES▼1,302.15
-36.50 (-2.73%)
VODAFONE IDEA▼7.88
-0.57 (-6.75%)
ZOMATO▼245.08
-3.91 (-1.57%)
RELIANCE POWER▼42.03
-1.00 (-2.32%)
INDIAN RENEWABLE ENERGY▼205.38
-6.60 (-3.11%)
ADANI POWER▼585.00
-12.35 (-2.07%)
YES BANK▼20.33
-0.38 (-1.83%)
STATE BANK OF INDIA▲829.85
8.65 (1.05%)
NHPC▼83.30
-0.83 (-0.99%)
HDFC BANK▼1,714.10
-23.20 (-1.34%)
OLA ELECTRIC MOBILITY LTD▼80.84
-2.00 (-2.41%)
JIO FIN SERVICES LTD▼319.85
-6.35 (-1.95%)
INDIAN OIL CORP▼138.93
-6.06 (-4.18%)
BHARAT ELECTRONICS▼284.15
-4.50 (-1.56%)
MRF▼1,20,876.75
-2453.55 (-1.99%)
GTL INFRA▼2.11
-0.07 (-3.21%)
ADANI PORT & SEZ▼1,349.25
-45.15 (-3.24%)
JAIPRAKASH POWER VENTURES▼17.88
-0.59 (-3.19%)
ITC▼484.60
-5.70 (-1.16%)
- Zota Health Care
Zota Health Care Share Price
ZOTA
₹607.15-₹2.95 (-0.48%) TodayLast updated on 04 Nov, 2024 | 15:43 IST
Zota Health Care Share Price Chart
Please wait...
About Zota Health Care
Zota Health Care Financials
Market cap  ₹1,603 Crs | Open ₹612.00 | Close ₹610.10 |
Circuit range ₹728.55 - ₹485.75 | Day range ₹599.95 - ₹615.00 | Year range ₹400.00 - ₹725.05 |
Volume 9,372 | Avg. traded ₹606.81 | Revenue (12m) ₹198 Crs |
Zota Health CareZota Health Care Limited is an India-based pharmaceutical company, which is engaged in manufacturing and marketing of pharmaceutical products catering to domestic and international markets. It engages in manufacturing, marketing, and exporting a range of pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Company’s business model comprises three verticals, namely Domestic, Exports and Retail Pharmacy Chain. Its Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products. Its products span across approximately 24 divisions, with a portfolio of over 4,000 therapeutic product categories such as generics, OTC products, allopathic, ayurvedic, and others. Its Retail Pharmacy Chain business vertical operates a chain of approximately 594 pharmacy stores under the brand Davaindia. Its Domestic products include AZIVAR-100 DT Tab, AZIVAR-250 Tab, AZIVAR-500 Tab, AZIVAR-CX Tab, among others.
Zota Health Care Key indicators
52 week high ₹725.05 | 52 week low ₹400.00 | P/E ratio |
P/B ratio 11.59 | ROE 3.13% | ROCE 4.57% |
Dividend yield 0.16% | Debt/Equity ratio 0.12 | EPS 1.31 |
Learn more
Featured in
Investment checklist: (4/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Zota Health Care Fundamentals
Zota Health Care Financial Ratios
Operating profit margin4.97% | Net profit margin2.03% |
ROE3.13% | ROA2.27% |
ROCE4.57% |
Learn more
Zota Health Care Shareholder returns
1 day -0.48% | 1 week | 1 month |
3 months -12.10% | 1 year | 3 years |
5 years |
Zota Health Care Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
Mon, Nov 4 2024 | ₹612.00 | ₹607.15 | -0.48% |
Fri, Nov 1 2024 | ₹609.90 | ₹610.10 | |
Thu, Oct 31 2024 | ₹609.00 | ₹603.95 | |
Wed, Oct 30 2024 | ₹608.60 | ₹603.40 | |
Tue, Oct 29 2024 | ₹600.70 | ₹602.65 | |
Mon, Oct 28 2024 | ₹587.95 | ₹597.75 | |
Fri, Oct 25 2024 | ₹589.75 | ₹584.25 | |
Thu, Oct 24 2024 | ₹588.60 | ₹583.45 | -0.38% |
Zota Health Care Shareholding Pattern
Promoters (62.4%) | Mutual Funds (0%) | Retail and other (36.6%) |
Foreign institutions-FII (0.01%) | Other domestic institutions (0.99%) |
Promoters
Learn more
Events
Corporate actions
Dividend • ₹1/share
Ex date 20 Sep 2024
Dividend • ₹1/share
Ex date 22 Sep 2023
Dividend • ₹1.5/share
Ex date 19 Sep 2022
Learn more
More
Stocks Similar to Zota Health Care
People also bought
Zota Health Care News
